Single Nucleotide Polymorphisms Associated with Colorectal Cancer Susceptibility and Loss of Heterozygosity in a Taiwanese Population

Given the significant racial and ethnic diversity in genetic variation, we are intrigued to find out whether the single nucleotide polymorphisms (SNPs) identified in genome-wide association studies of colorectal cancer (CRC) susceptibility in East Asian populations are also relevant to the population of Taiwan. Moreover, loss of heterozygosity (LOH) may provide insight into how variants alter CRC risk and how regulatory elements control gene expression. To investigate the racial and ethnic diversity of CRC-susceptibility genetic variants and their relevance to the Taiwanese population, we genotyped 705 CRC cases and 1,802 healthy controls (Taiwan Biobank) for fifteen previously reported East Asian CRC-susceptibility SNPs and four novel genetic variants identified by whole-exome sequencing. We found that rs10795668 in FLJ3802842 and rs4631962 in CCND2 were significantly associated with CRC risk in the Taiwanese population. The previously unreported rs1338565 was associated with a significant increased risk of CRC. In addition, we also genotyped tumor tissue and paired adjacent normal tissues of these 705 CRC cases to search for LOH, as well as risk-associated and protective alleles. LOH analysis revealed preferential retention of three SNPs, rs12657484, rs3802842, and rs4444235, in tumor tissues. rs4444235 has been recently reported to be a cis-acting regulator of BMP4 gene; in this study, the C allele was preferentially retained in tumor tissues (p = 0.0023). rs4631962 and rs10795668 contribute to CRC risk in the Taiwanese and East Asian populations, and the newly identified rs1338565 was specifically associated with CRC, supporting the ethnic diversity of CRC-susceptibility SNPs. LOH analysis suggested that the three CRC risk variants, rs12657484, rs3802842, and rs4444235, exhibited somatic allele-specific imbalance and might be critical during neoplastic progression.

[1]  Á. Carracedo,et al.  Genetic susceptibility variants associated with colorectal cancer prognosis. , 2013, Carcinogenesis.

[2]  Ben Zhang,et al.  Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer , 2012, Nature Genetics.

[3]  Yongping Cui,et al.  Replication Study in Chinese Population and Meta-Analysis Supports Association of the 11q23 Locus with Colorectal Cancer , 2012, PloS one.

[4]  Y. Teo,et al.  Association of Caucasian-Identified Variants with Colorectal Cancer Risk in Singapore Chinese , 2012, PloS one.

[5]  Lai Wei,et al.  Evaluation of Allele-Specific Somatic Changes of Genome-Wide Association Study Susceptibility Alleles in Human Colorectal Cancers , 2012, PloS one.

[6]  I. Petersen,et al.  Loss of desmocollin 1-3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma , 2012, International Journal of Colorectal Disease.

[7]  A. Constantin,et al.  Single nucleotide polymorphisms in colorectal cancer: associations with tumor site and TNM stage. , 2012, Journal of gastrointestinal and liver diseases : JGLD.

[8]  Steven Gallinger,et al.  cis-Expression QTL Analysis of Established Colorectal Cancer Risk Variants in Colon Tumors and Adjacent Normal Tissue , 2012, PloS one.

[9]  C. Carlson,et al.  Meta-analysis of new genome-wide association studies of colorectal cancer risk , 2011, Human Genetics.

[10]  H. Ikeuchi,et al.  Differential gene expression signatures between colorectal cancers with and without KRAS mutations: crosstalk between the KRAS pathway and other signalling pathways. , 2011, European journal of cancer.

[11]  Robert L. Sutherland,et al.  Cyclin D as a therapeutic target in cancer , 2011, Nature Reviews Cancer.

[12]  Steven Gallinger,et al.  Multiple Common Susceptibility Variants near BMP Pathway Loci GREM1, BMP4, and BMP2 Explain Part of the Missing Heritability of Colorectal Cancer , 2011, PLoS genetics.

[13]  L. Aaltonen,et al.  Systematic search for enhancer elements and somatic allelic imbalance at seven low-penetrance colorectal cancer predisposition loci , 2011, BMC Medical Genetics.

[14]  M. Oshimura,et al.  Identification of PITX1 as a TERT Suppressor Gene Located on Human Chromosome 5 , 2011, Molecular and Cellular Biology.

[15]  Y. Kamatani,et al.  Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population , 2011, Gut.

[16]  P. Sham,et al.  Replication study of SNP associations for colorectal cancer in Hong Kong Chinese , 2010, British Journal of Cancer.

[17]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[18]  A. Levine,et al.  The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes , 2010, Science.

[19]  R. Scott,et al.  Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome , 2010, Journal of Medical Genetics.

[20]  B. Henderson,et al.  Generalizability and Epidemiologic Characterization of Eleven Colorectal Cancer GWAS Hits in Multiple Populations , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[21]  A. Skol,et al.  Genetic heterogeneity in colorectal cancer associations between African and European americans. , 2010, Gastroenterology.

[22]  L. Påhlman,et al.  Association studies on 11 published colorectal cancer risk loci , 2010, British Journal of Cancer.

[23]  W. Tan,et al.  Risk of Genome-Wide Association Study–Identified Genetic Variants for Colorectal Cancer in a Chinese Population , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[24]  Olivia Fletcher,et al.  Architecture of inherited susceptibility to common cancer , 2010, Nature Reviews Cancer.

[25]  D. Jayne,et al.  Expression of cyclin D2 is an independent predictor of the development of hepatic metastasis in colorectal cancer , 2010, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[26]  Nuria Lopez-Bigas,et al.  IntOGen: integration and data mining of multidimensional oncogenomic data , 2010, Nature Methods.

[27]  C Schafmayer,et al.  COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer , 2009, British Journal of Cancer.

[28]  Hideo Tanaka,et al.  Association between an 8q24 locus and the risk of colorectal cancer in Japanese , 2009, BMC Cancer.

[29]  J. Houwing-Duistermaat,et al.  Enrichment of Low Penetrance Susceptibility Loci in a Dutch Familial Colorectal Cancer Cohort , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[30]  K. Matsuo,et al.  A Genome-Wide Association Analysis Identified a Novel Susceptible Locus for Pathological Myopia at 11q24.1 , 2009, PLoS genetics.

[31]  Ken Chen,et al.  VarScan: variant detection in massively parallel sequencing of individual and pooled samples , 2009, Bioinform..

[32]  Huan Yang,et al.  A Novel Polymorphism rs1329149 of CYP2E1 and a Known Polymorphism rs671 of ALDH2 of Alcohol Metabolizing Enzymes Are Associated with Colorectal Cancer in a Southwestern Chinese Population , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[33]  Huanming Yang,et al.  SNP detection for massively parallel whole-genome resequencing. , 2009, Genome research.

[34]  P. Broderick,et al.  The colorectal cancer risk at 18q21 is caused by a novel variant altering SMAD7 expression. , 2009, Genome research.

[35]  A. Tenesa,et al.  New insights into the aetiology of colorectal cancer from genome-wide association studies , 2009, Nature Reviews Genetics.

[36]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[37]  Steven Gallinger,et al.  Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer , 2008, Nature Genetics.

[38]  Julian Peto,et al.  Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer. , 2008, Human molecular genetics.

[39]  F. Chan,et al.  Asia Pacific consensus recommendations for colorectal cancer screening , 2008, Gut.

[40]  B. Aggarwal,et al.  Cancer is a Preventable Disease that Requires Major Lifestyle Changes , 2008, Pharmaceutical Research.

[41]  John D Potter,et al.  Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. , 2008, JAMA.

[42]  I. Deary,et al.  Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21 , 2008, Nature Genetics.

[43]  Julian Peto,et al.  A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3 , 2008, Nature Genetics.

[44]  Xue Zhang,et al.  Expression of pituitary homeobox 1 gene in human gastric carcinogenesis and its clinicopathological significance. , 2008, World journal of gastroenterology.

[45]  M. Harper,et al.  Mislocalization of human transcription factor MOK2 in the presence of pathogenic mutations of lamin A/C , 2008, Biology of the cell.

[46]  Oliver Sieber,et al.  A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk , 2007, Nature Genetics.

[47]  Suet Yi Leung,et al.  Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors , 2007, Proceedings of the National Academy of Sciences.

[48]  P. Lobie,et al.  Transcriptional activation of p53 by Pitx1 , 2007, Cell Death and Differentiation.

[49]  Oliver Sieber,et al.  A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 , 2007, Nature Genetics.

[50]  J. Sung,et al.  Colorectal neoplasm in asymptomatic Asians: a prospective multinational multicenter colonoscopy survey. , 2007, Gastrointestinal endoscopy.

[51]  T. Ravikumar,et al.  Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells. , 2007, Experimental cell research.

[52]  M. Pacyna‐Gengelbach,et al.  Decreased PITX1 homeobox gene expression in human lung cancer. , 2007, Lung cancer.

[53]  Jukka-Pekka Mecklin,et al.  Explaining the Familial Colorectal Cancer Risk Associated with Mismatch Repair (MMR)-Deficient and MMR-Stable Tumors , 2007, Clinical Cancer Research.

[54]  Á. Carracedo,et al.  A multiplex assay with 52 single nucleotide polymorphisms for human identification , 2006, Electrophoresis.

[55]  P. Danenberg,et al.  Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. , 2005, Surgery.

[56]  W. G. Hill,et al.  Measures of human population structure show heterogeneity among genomic regions. , 2005, Genome research.

[57]  S. Walfisch,et al.  Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas , 2005, British Journal of Cancer.

[58]  R. Bernards,et al.  A Genetic Screen Identifies PITX1 as a Suppressor of RAS Activity and Tumorigenicity , 2005, Cell.

[59]  Ossama Tawfik,et al.  BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt–β-catenin signaling , 2004, Nature Genetics.

[60]  M. Kress,et al.  In vivo and in vitro interaction between human transcription factor MOK2 and nuclear lamin A/C. , 2002, Nucleic Acids Research.

[61]  M. Kress,et al.  The Zinc Finger Transcription Factor, MOK2, Negatively Modulates Expression of the Interphotoreceptor Retinoid-binding Protein Gene, IRBP * , 2001, The Journal of Biological Chemistry.

[62]  P. Polakis.  Wnt signaling and cancer. , 2000, Genes & development.

[63]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[64]  M. Barrett,et al.  Barrett's esophagus: ordering the events that lead to cancer. , 1996, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[65]  R. Greenberg,et al.  Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[67]  Y. Nakamura,et al.  Allelotype of non-small cell lung carcinoma--comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. , 1992, Cancer research.

[68]  Y. Nakamura,et al.  Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. , 1992, Cancer research.

[69]  A. Tanigami,et al.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. , 1990, Cancer research.

[70]  R. White,et al.  Allelotype of human malignant astrocytoma. , 1990, Cancer research.

[71]  Y. Nakamura,et al.  Allelotype of colorectal carcinomas. , 1989, Science.

[72]  W. Cavenee,et al.  Genetics of cancer predisposition. , 1987, Cancer research.

[73]  A. Knudson.  Hereditary cancer, oncogenes, and antioncogenes. , 1985, Cancer research.

[74]  R. Houlston,et al.  Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome. , 2009, Gastroenterology.

[75]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[76]  M. Brown,et al.  Tumor suppressor genes and human cancer. , 1997, Advances in genetics.

[77]  E. Stanbridge.  Human tumor suppressor genes. , 1990, Annual review of genetics.

[78]  E. Somers.  International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[79]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.